Tag: Abbott
In brief: Latest UHC-Synapse deal, Dexcom stolen sensors, WeOxy debut
May 29, 2026HME News Staff
SKOKIE, Ill. – UnitedHealthcare has announced that Synapse Health will manage durable medical equipment (DME) orders for certain UnitedHealthcare Medicare Advantage plans in additional states beginning Sept. 1, 2026.
For individual HMO & PPO plans, Synapse Health will manage DME for members in Connecticut, District of Columbia, Delaware, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania and Rhode Island.
For chronic special needs plans (C-SNP), Synapse...
Abbott secures European clearance for dual glucose/ketone device
May 27, 2026HME News Staff
ABBOTT PARK, Ill. – Abbott has secured CE Mark for a dual glucose ketone sensing technology for people with diabetes. Branded as Libre Duo and Libre Duo 10 Day, the systems are designed to continuously measure glucose and ketone levels every minute, providing real-time visibility into both glucose levels needed for daily diabetes management and rising ketones that can lead to a diabetic ketoacidosis (DKA) emergency. The company says this marks the first time people with diabetes will be able...
Abbott’s new Libre app feature helps with in-the-moment food decisions
January 5, 2026HME News Staff
ABBOTT PARK, Ill. - Abbott has launched Libre Assist, a feature within the Libre app designed to help people living with diabetes better understand how the foods they eat affect their glucose levels. The company says, unlike traditional food logging apps that only give feedback after a meal is logged, Libre Assist helps people make informed mealtime decisions before they eat.
"The Libre Assist feature is a gamechanger for me," said Shirley Bovshow,...
In brief: Resmed cleared for smart settings, Perry Bernocchi promoted, Lingo access expanded
December 9, 2025HME News Staff
SAN DIEGO – Resmed has received clearance from the U.S. Food and Drug Administration (FDA) for an artificial intelligence (AI)-enabled device that recommends personalized comfort settings to help people with obstructive sleep apnea (OSA) start and stay on CPAP therapy.
Personalized Therapy Comfort Settings (PTCS), which will be marketed as Smart Comfort, will launch in early 2026 in a limited beta version in the United States for new users of myAir paired...
Abbott expands access to Lingo CGM & app
December 9, 2025HME News Staff
ABBOTT PARK, Ill. - Abbott has announced that Lingo, an over-the-counter continuous glucose monitor (CGM) and app, is now available for Android devices. Already available for Apple iOS devices, the company says this expansion gives millions more people access to real-time glucose data, empowering informed choices that help support better energy, sleep, focus and overall well-being. "The need for more glucose awareness is clear," said Amy McKenzie, Ph.D., head of...
Abbott issues correction for Freestyle Libre 3 and 3 Plus sensors
November 26, 2025HME News Staff
ABBOTT PARK, Ill. — Abbott has initiated a medical device correction for certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors in the United States after internal testing determined that some sensors may provide incorrect low glucose readings.
This action involves approximately 3 million Libre 3 and Libre 3 Plus sensors in the U.S. from one production line, about half of which are estimated to have expired or been used. Globally, Abbott has received reports of 736 severe...
In brief: CGM overpayments, Abbott device correction, veterans’ Parkinson’s risk
November 26, 2025HME News Staff
WASHINGTON – Medicare payments for continuous glucose monitors (CGMs) and supplies exceeded supplier acquisition costs by $377 million (or 69%) and their total estimated costs by $70 million (or 8%) in one year, according to a new report from the Office of Inspector General (OIG).
Medicare Part B payments for CGMs and supplies rose from $109 million in 2018 to $1.3 billion in 2023. Of note, CMS expanded CGM coverage to beneficiaries with Type 2 diabetes in 2023
The OIG compared...
Tandem integrates, partners with Abbott
June 23, 2025HME News Staff
SAN DIEGO – Tandem Diabetes Care has announced that the Tandem t:slimX2 insulin pump with Control-IQ+ automated insulin delivery (AID) technology now works with Abbott’s FreeStyle Libre 3 Plus continuous glucose monitoring (CGM) sensor. The company has initiated an early access program in the United States and intends to scale availability in the second half of 2025. “Diabetes management is not one-size-fits-all and it is critical for people living with diabetes to be able to personalize...
In brief: KabaFusion expands footprint, CGM reduces hospitalizations, Apnimed shares positive results
May 21, 2025HME News Staff
LEXINGTON, Mass. – KabaFusion has closed on the acquisition of six locations from Coram that will serve as pharmacies and ambulatory infusion suites.
The transaction will expand KabaFusion’s ability to serve a growing number of patients nationwide and strengthen its commitment to deliver high-quality patient care across a broad range of therapies, the company says.
“Our expansion will enable KabaFusion to serve a greater number of patients with superior...
Studies link Abbott CGM with reduced hospitalizations
May 19, 2025HME News Staff
ABBOTT PARK, Ill. – Abbott’s FreeStyle Libre continuous glucose monitoring technology is associated with a significant reduction in the risk of hospitalization for heart complications in people with diabetes, according to the results of the company’s REFLECT real-world studies.
For the first time, Abbott says, data show that CGM technology can help lessen the severity of cardiovascular complications – regardless of a prior history of low blood sugar events or heart...